The Impact of Emicizumab Prophylaxis on Hospitalizations and Emergency Department Visits Among Hemophilia A Patients Is Age Related
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Dan Geller, Ivan Budnik, Tlalit Barhod, Omri Cohen, Tamar Brutman‐Barazani, Orly Efros, Aharon Lubetsky, Shadan Lalezari, Sarina Levy‐Mendelovich, Gili Kenet, Assaf A. Barg |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Emicizumab in Previously Untreated Patients and Minimally Treated Patients With Hemophilia A: A Comparative Study Between Two International Cohorts
por: Sarina Levy‐Mendelovich, et al.
Publicado: (2025)
por: Sarina Levy‐Mendelovich, et al.
Publicado: (2025)
Pediatric splenic infarction: Assessment of associated clinical conditions and outcome
por: Evgeny Grishin, et al.
Publicado: (2024)
por: Evgeny Grishin, et al.
Publicado: (2024)
Emicizumab prophylaxis in infants: Single‐centre experience
por: Sarina Levy‐Mendelovich, et al.
Publicado: (2024)
por: Sarina Levy‐Mendelovich, et al.
Publicado: (2024)
Milds Matter—Feasibility of Emicizumab Prophylaxis in Mild Hemophilia
por: Kyle Davis, et al.
Publicado: (2026)
por: Kyle Davis, et al.
Publicado: (2026)
Importance of Inhibitor Surveillance During Emicizumab Prophylaxis in Young Children With Hemophilia: An Illustrative Case Series
por: Kelly A. Bush, et al.
Publicado: (2025)
por: Kelly A. Bush, et al.
Publicado: (2025)
Safety of recombinant activated factor VII for treatment of breakthrough bleeds in patients with congenital haemophilia A and inhibitors receiving emicizumab prophylaxis: Review of the real‐world evidence
por: Gili Kenet, et al.
Publicado: (2024)
por: Gili Kenet, et al.
Publicado: (2024)
Dental Management of Persons With Haemophilia Receiving Emicizumab Prophylaxis
por: Branislav V. Bajkin, et al.
Publicado: (2026)
por: Branislav V. Bajkin, et al.
Publicado: (2026)
Excellent response to treatment with hydroxychloroquine in pediatric patients with SLE‐related immune thrombocytopenia
por: Dafna Brik‐Simon, et al.
Publicado: (2024)
por: Dafna Brik‐Simon, et al.
Publicado: (2024)
Concurrent Acquired Hemophilia A and Lupus Anticoagulant Managed With Emicizumab and Immunosuppression: A Case Report
por: Julie Williamson, et al.
Publicado: (2026)
por: Julie Williamson, et al.
Publicado: (2026)
Myeloid Cell Function and Cytokine Profiles in Paediatric Haemophilia A: Insights From FVIII and Emicizumab Prophylaxis
por: Alessia Cottonaro, et al.
Publicado: (2026)
por: Alessia Cottonaro, et al.
Publicado: (2026)
Simultaneous temperature estimation and nonuniformity correction from multiple frames
por: Oz, Navot, et al.
Publicado: (2023)
por: Oz, Navot, et al.
Publicado: (2023)
Differences Between Sweden and Greece in Joint Outcomes Assessed by Ultrasound in Adolescents With Severe Haemophilia on Prophylaxis: Data From the PedNet Registry
por: Aikaterini Michalopoulou, et al.
Publicado: (2025)
por: Aikaterini Michalopoulou, et al.
Publicado: (2025)
Emergency Department Visits for Bleeding by Adults Aged ≥ 80 Years Receiving Direct‐Acting Oral Anticoagulants
por: Andrew I. Geller, et al.
Publicado: (2025)
por: Andrew I. Geller, et al.
Publicado: (2025)
Lifetime Cost‐Utility Analysis of Emicizumab Prophylaxis in Severe Haemophilia A Without Inhibitors in China: A Markov Model Analysis
por: Han Bao, et al.
Publicado: (2026)
por: Han Bao, et al.
Publicado: (2026)
Multicentre Retrospective and Prospective Analysis of Data on Emicizumab and Factor VIII Prophylaxis in Children With Severe Haemophilia A: Egypt‐Compare Study
por: Tamer Hassan, et al.
Publicado: (2026)
por: Tamer Hassan, et al.
Publicado: (2026)
ORPHEE: A Real‐World Study on rIX‐FP Prophylaxis Use in Adolescent/Adult Patients With Hemophilia B
por: Fabienne Volot, et al.
Publicado: (2024)
por: Fabienne Volot, et al.
Publicado: (2024)
Low‐Dose Emicizumab Versus Low‐/Intermediate‐Dose Factor VIII Secondary Prophylaxis for Noninhibitor Haemophilia A Patients With Severe Bleeding Phenotype
por: Nuchanun Kessakorn, et al.
Publicado: (2024)
por: Nuchanun Kessakorn, et al.
Publicado: (2024)
Petrography and geochemistry of the Ab-e-Haji Formation in central Iran: implications for provenance and tectonic setting in the southern part of the Tabas block
por: Mahdi Shadan
Publicado: (2013)
por: Mahdi Shadan
Publicado: (2013)
Compliance and Resistance Within Neoliberal Academia
por: Gair, Susan, et al.
Publicado: (2022)
por: Gair, Susan, et al.
Publicado: (2022)
Respiratory morbidity among offspring misclassified as growth restricted
por: Omri Zamstein, et al.
Publicado: (2024)
por: Omri Zamstein, et al.
Publicado: (2024)
The Primary Flare Following a Stellar Collision in a Galactic Nucleus
por: Brutman, Yuval, et al.
Publicado: (2024)
por: Brutman, Yuval, et al.
Publicado: (2024)
Predicting Emergency Department Visits for Patients with Type II Diabetes
por: Alizadeh, Javad M, et al.
Publicado: (2024)
por: Alizadeh, Javad M, et al.
Publicado: (2024)
Incarceration and Psychiatric Emergency Department Visits Among Black Americans
por: ABHERY DAS, et al.
Publicado: (2025)
por: ABHERY DAS, et al.
Publicado: (2025)
Emicizumab and asparaginase, A first experience to share
por: Laurie Goubeau, et al.
Publicado: (2024)
por: Laurie Goubeau, et al.
Publicado: (2024)
Identifying User Goals from UI Trajectories
por: Berkovitch, Omri, et al.
Publicado: (2024)
por: Berkovitch, Omri, et al.
Publicado: (2024)
A post hoc analysis of PROTECT VIII kids assessing long‐term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A
por: Sanjay Ahuja, et al.
Publicado: (2024)
por: Sanjay Ahuja, et al.
Publicado: (2024)
Orientación para la promoción de la ordenación medioambiental del desarrollo de la acuicultura costera / U. C. Barg
por: Barg, U. C
Publicado: (1995)
por: Barg, U. C
Publicado: (1995)
BASES NEUROBIOLÓGICAS DEL APEGO. REVISIÓN TEMÁTICA
por: Gabriel Barg Beltrame
Publicado: (2011)
por: Gabriel Barg Beltrame
Publicado: (2011)
On the representation-free formalism in quantum mechanics
por: Efros, V. D.
Publicado: (2022)
por: Efros, V. D.
Publicado: (2022)
Beyond Data Scarcity: A Frequency-Driven Framework for Zero-Shot Forecasting
por: Nochumsohn, Liran, et al.
Publicado: (2024)
por: Nochumsohn, Liran, et al.
Publicado: (2024)
U.S. Emergency Department Visits for Dizziness and Vertigo From 2016 to 2022
por: Milina M. Miulli, et al.
Publicado: (2026)
por: Milina M. Miulli, et al.
Publicado: (2026)
Relationship between Dose, Factor IX Activity Levels and Bleeding Probability for rIX‐FP Prophylaxis in Hemophilia B: A Repeated Time‐to‐Event Analysis
por: Sjoerd F. Koopman, et al.
Publicado: (2025)
por: Sjoerd F. Koopman, et al.
Publicado: (2025)
Pregnancy outcomes by hyperemesis gravidarum severity and time of diagnosis: A retrospective cohort study
por: Omri Porgador, et al.
Publicado: (2024)
por: Omri Porgador, et al.
Publicado: (2024)
The association between preterm delivery and autism spectrum disorder in childhood: A retrospective cohort study
por: Sapir Ellouk, et al.
Publicado: (2025)
por: Sapir Ellouk, et al.
Publicado: (2025)
La empresa educativa Chilena
por: Jenny Assaél Budnik
Publicado: (2011)
por: Jenny Assaél Budnik
Publicado: (2011)
Analytical approximations as close as desired to special functions
por: Orly, Aviv
Publicado: (2024)
por: Orly, Aviv
Publicado: (2024)
Experimentos de sensibilidad: fusión músico-literaria / Orly Rosales
por: Rosales, Orly
por: Rosales, Orly
El Silogismo Roto: Los Efectos Legales de la Tenencia y el Consumo de Droga en el Ordenamiento Interno Ecuatoriano
por: Orly Delgado
Publicado: (2018)
por: Orly Delgado
Publicado: (2018)
Erratum to “Relationship between Dose, Factor IX Activity Levels and Bleeding Probability for rIX ‐ FP Prophylaxis in Hemophilia B: A Repeated Time‐to‐Event Analysis”
Publicado: (2025)
Publicado: (2025)
The Impact of AI on Perceived Job Decency and Meaningfulness: A Case Study
por: Ghosh, Kuntal, et al.
Publicado: (2024)
por: Ghosh, Kuntal, et al.
Publicado: (2024)
Ejemplares similares
-
Emicizumab in Previously Untreated Patients and Minimally Treated Patients With Hemophilia A: A Comparative Study Between Two International Cohorts
por: Sarina Levy‐Mendelovich, et al.
Publicado: (2025) -
Pediatric splenic infarction: Assessment of associated clinical conditions and outcome
por: Evgeny Grishin, et al.
Publicado: (2024) -
Emicizumab prophylaxis in infants: Single‐centre experience
por: Sarina Levy‐Mendelovich, et al.
Publicado: (2024) -
Milds Matter—Feasibility of Emicizumab Prophylaxis in Mild Hemophilia
por: Kyle Davis, et al.
Publicado: (2026) -
Importance of Inhibitor Surveillance During Emicizumab Prophylaxis in Young Children With Hemophilia: An Illustrative Case Series
por: Kelly A. Bush, et al.
Publicado: (2025)